XML 72 R61.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stockholders' Equity (Schedule Of Stockholders' Equity) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Stockholders' Equity [Line Items]        
Beginning balance     $ 958,909  
Net income (loss) $ 12,884 $ 10,041 6,053 $ 14,515
Cash dividends and distributions declared     (27,837)  
Other comprehensive loss before reclassifications     (1,395)  
Amounts reclassified from accumulated other comprehensive income (loss)     2,506  
Total other comprehensive income, net of tax 4,069 $ 2,779 1,111 $ 9,945
Consolidation of BioProcess Algae     2,807  
Repurchase of common stock     (6,005)  
Issuance of 4.125% convertible notes due 2022, net of tax     24,350  
Stock-based compensation     $ 4,519  
Stock options exercised, Shares     140,000  
Stock options exercised     $ 1,632  
Ending balance $ 965,539   $ 965,539  
Common Units [Member]        
Stockholders' Equity [Line Items]        
Beginning balance, Shares     45,282,000  
Beginning balance     $ 45  
Stock-based compensation, Shares     630,000  
Stock-based compensation     $ 1  
Stock options exercised, Shares     140,000  
Ending balance, Shares 46,052,000   46,052,000  
Ending balance $ 46   $ 46  
Additional Paid-In Capital [Member]        
Stockholders' Equity [Line Items]        
Beginning balance     577,787  
Transfer of assets to Green Plains Partners LP     47,389  
Investment in BioProcess Algae     928  
Issuance of 4.125% convertible notes due 2022, net of tax     24,350  
Stock-based compensation     4,436  
Stock options exercised     1,632  
Ending balance 656,522   656,522  
Retained Earnings [Member]        
Stockholders' Equity [Line Items]        
Beginning balance     290,974  
Net income (loss)     (8,019)  
Cash dividends and distributions declared     (13,820)  
Ending balance 269,135   269,135  
Accum. Other Comp. Income (Loss) [Member]        
Stockholders' Equity [Line Items]        
Beginning balance     (1,165)  
Other comprehensive loss before reclassifications     (1,395)  
Amounts reclassified from accumulated other comprehensive income (loss)     2,506  
Total other comprehensive income, net of tax     1,111  
Ending balance $ (54)   $ (54)  
Treasury Stock [Member]        
Stockholders' Equity [Line Items]        
Beginning balance, Shares     7,392,000  
Beginning balance     $ (69,811)  
Repurchase of common stock, Shares     323,000  
Repurchase of common stock     $ (6,005)  
Ending balance, Shares 7,715,000   7,715,000  
Ending balance $ (75,816)   $ (75,816)  
Total Green Plains Stockholders' Equity [Member]        
Stockholders' Equity [Line Items]        
Beginning balance     797,830  
Net income (loss)     (8,019)  
Cash dividends and distributions declared     (13,820)  
Other comprehensive loss before reclassifications     (1,395)  
Amounts reclassified from accumulated other comprehensive income (loss)     2,506  
Total other comprehensive income, net of tax     1,111  
Transfer of assets to Green Plains Partners LP     47,389  
Investment in BioProcess Algae     928  
Repurchase of common stock     (6,005)  
Issuance of 4.125% convertible notes due 2022, net of tax     24,350  
Stock-based compensation     4,437  
Stock options exercised     1,632  
Ending balance 849,833   849,833  
Noncontrolling Interests [Member]        
Stockholders' Equity [Line Items]        
Beginning balance     161,079  
Net income (loss)     14,072  
Cash dividends and distributions declared     (14,017)  
Transfer of assets to Green Plains Partners LP     (47,389)  
Consolidation of BioProcess Algae     2,807  
Investment in BioProcess Algae     (928)  
Stock-based compensation     82  
Ending balance $ 115,706   $ 115,706